BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sheyhidin I, Nabi G, Hasim A, Zhang RP, Ainiwaer J, Ma H, Wang H. Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma. World J Gastroenterol 2011; 17(32): 3745-3751 [PMID: 21990957 DOI: 10.3748/wjg.v17.i32.3745]
URL: https://www.wjgnet.com/1007-9327/full/v17/i32/3745.htm
Number Citing Articles
1
Khan Shahanavaj, Ignacio Gil-Bazo, Marta Castiglia, Giuseppe Bronte, Francesco Passiglia, Anna P Carreca, José Luis del Pozo, Antonio Russo, Marc Peeters, Christian Rolfo. Cancer and the microbiome: potential applications as new tumor biomarkerExpert Review of Anticancer Therapy 2015; 15(3): 317 doi: 10.1586/14737140.2015.992785
2
Heikki Huhta, Olli Helminen, Petri P. Lehenkari, Juha Saarnio, Tuomo J. Karttunen, Joonas H. Kauppila. Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinomaOncotarget 2016; 7(17): 23658 doi: 10.18632/oncotarget.8151
3
Liang Chang, Fengjie Guo, Yalei Lv, Yudong Wang, Bingjie Huo, Long Wang, Wei Liu. The inhibitory effects of Endostar combined with chemotherapy on human esophageal squamous cell carcinoma xenograft in miceMolecular Biology Reports 2013; 40(1): 669 doi: 10.1007/s11033-012-2106-x
4
Kian-Huat Lim. Cancer Therapeutic Targets2013; : 1 doi: 10.1007/978-1-4614-6613-0_70-2
5
Qiong Dai, Xing Pu Li, Li Chai, Han An Long, Zhi Hui Yang. Polymorphisms of Toll-like receptor 9 are associated with nasopharyngeal carcinoma susceptibilityTumor Biology 2014; 35(4): 3247 doi: 10.1007/s13277-013-1424-5
6
Daye Cheng, Yiwen Hao, Wenling Zhou, Yiran Ma. Association between Toll-like receptor 3 polymorphisms and cancer risk: a meta-analysisTumor Biology 2014; 35(8): 7837 doi: 10.1007/s13277-014-2049-z
7
Yukun Zu, Wei Ping, Taoran Deng, Ni Zhang, Xiangning Fu, Wei Sun. Lipopolysaccharide-induced toll-like receptor 4 signaling in esophageal squamous cell carcinoma promotes tumor proliferation and regulates inflammatory cytokines expressionDiseases of the Esophagus 2016;  doi: 10.1111/dote.12466
8
Johanna C. Klein, Katrin Moses, Gennadiy Zelinskyy, Simon Sody, Jan Buer, Stephan Lang, Iris Helfrich, Ulf Dittmer, Carsten J. Kirschning, Sven Brandau. Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growthNature Communications 2017; 8(1) doi: 10.1038/ncomms14600
9
Sedigheh Baakhlagh, Bahareh Kashani, Zahra Zandi, Davood Bashash, Malihe Moradkhani, Ali Nasrollahzadeh, Marjan Yaghmaei, Seyed A. Mousavi, Seyed H. Ghaffari. Toll-like receptor 4 signaling pathway is correlated with pathophysiological characteristics of AML patients and its inhibition using TAK-242 suppresses AML cell proliferationInternational Immunopharmacology 2021; 90: 107202 doi: 10.1016/j.intimp.2020.107202
10
Cindy Patinote, Nour Bou Karroum, Georges Moarbess, Natalina Cirnat, Issam Kassab, Pierre-Antoine Bonnet, Carine Deleuze-Masquéfa. Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposesEuropean Journal of Medicinal Chemistry 2020; 193: 112238 doi: 10.1016/j.ejmech.2020.112238
11
A.A. Khan, Z. Khan, S. Warnakulasuriya. Cancer-associated toll-like receptor modulation and insinuation in infection susceptibility: association or coincidence?Annals of Oncology 2016; 27(6): 984 doi: 10.1093/annonc/mdw053
12
Kian-Huat Lim. Cancer Therapeutic Targets2017; : 495 doi: 10.1007/978-1-4419-0717-2_70
13
Vinita Mishra, Chandramani Pathak. Human Toll-Like Receptor 4 (hTLR4): Structural and functional dynamics in cancerInternational Journal of Biological Macromolecules 2019; 122: 425 doi: 10.1016/j.ijbiomac.2018.10.142
14
Ju-Hee Han, Shin-Young Park, Jin-Bum Kim, Sung-Dae Cho, Bumseok Kim, Bo-Yeon Kim, Min-Jung Kang, Dong-Jae Kim, Jae-Hak Park, Jong-Hwan Park. TLR7 Expression is Decreased During Tumour Progression in Transgenic Adenocarcinoma of Mouse Prostate Mice and Its Activation Inhibits Growth of Prostate Cancer CellsAmerican Journal of Reproductive Immunology 2013; 70(4): 317 doi: 10.1111/aji.12146
15
Bahareh Kashani, Zahra Zandi, Mohammad Reza Karimzadeh, Davood Bashash, Ali Nasrollahzadeh, Seyed H. Ghaffari. Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancersImmunologic Research 2019; 67(6): 505 doi: 10.1007/s12026-019-09113-8
16
Romy E. Verbeek, Peter D. Siersema, Fiebo J. Ten Kate, Kees Fluiter, Rhonda F. Souza, Frank P. Vleggaar, Pauline Bus, Jantine W. P. M. van Baal. Toll-like receptor 4 activation in Barrett’s esophagus results in a strong increase in COX-2 expressionJournal of Gastroenterology 2014; 49(7): 1121 doi: 10.1007/s00535-013-0862-6
17
Michael Linnebacher, Claudia Maletzki, Ulrike Klier, Ernst Klar. Bacterial immunotherapy of gastrointestinal tumorsLangenbeck's Archives of Surgery 2012; 397(4): 557 doi: 10.1007/s00423-011-0892-6
18
Yasuhiro Nihon-Yanagi, Megumi Wakayama, Naobumi Tochigi, Fumi Saito, Hideaki Ogata, Kazutoshi Shibuya, Anjali Mishra. Immunohistochemical Analysis of Toll-Like Receptors, MyD88, and TRIF in Human Papillary Thyroid Carcinoma and Anaplastic Thyroid CarcinomaJournal of Thyroid Research 2021; 2021: 1 doi: 10.1155/2021/4226491
19
Fatma E. Mohamed, Rajai M. Al-Jehani, Shane S. Minogue, Fausto Andreola, Alison Winstanley, Steven W.M. Olde Damink, Abeba Habtesion, Massimo Malagó, Nathan Davies, Tu Vinh Luong, Amar P. Dhillon, Rajeshwar P. Mookerjee, Dipok K. Dhar, Rajiv Jalan. Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinomaLiver International 2015; 35(3): 1063 doi: 10.1111/liv.12626
20
Zahra Zandi, Bahareh Kashani, Ensieh M. Poursani, Davood Bashash, Majid Kabuli, Majid Momeny, Seyedeh H. Mousavi-pak, Fatemeh Sheikhsaran, Kamran Alimoghaddam, Seyed A. Mousavi, Seyed H. Ghaffari. TLR4 blockade using TAK-242 suppresses ovarian and breast cancer cells invasion through the inhibition of extracellular matrix degradation and epithelial-mesenchymal transitionEuropean Journal of Pharmacology 2019; 853: 256 doi: 10.1016/j.ejphar.2019.03.046
21
Lauri Jouhi, Neeta Datta, Suvi Renkonen, Timo Atula, Antti Mäkitie, Caj Haglund, Abdirisak Ahmed, Stina Syrjänen, Reidar Grénman, Eeva Auvinen, Sanna Lehtonen, Jaana Hagström. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma—an in vivo and in vitro studyTumor Biology 2015; 36(10): 7755 doi: 10.1007/s13277-015-3494-z
22
E. Visser, I. A. Franken, L. A. A. Brosens, W. W. J. de Leng, E. Strengman, J. A. Offerhaus, J. P. Ruurda, R. van Hillegersberg. Targeted next-generation sequencing of commonly mutated genes in esophageal adenocarcinoma patients with long-term survivalDiseases of the Esophagus 2017; 30(9): 1 doi: 10.1093/dote/dox058
23
Shengwei Han, Wenguang Xu, Zhiyong Wang, Xiaofeng Qi, Yufeng Wang, Yanhong Ni, Hao Shen, Qingang Hu, Wei Han. Crosstalk between the HIF-1 and Toll-like receptor/nuclear factor-κB pathways in the oral squamous cell carcinoma microenvironmentOncotarget 2016; 7(25): 37773 doi: 10.18632/oncotarget.9329
24
Lei Li, Feng-Wei Cheng, Fang Wang, Bo Jia, Xin Luo, Sheng-Quan Zhang. The activation of TLR7 regulates the expression of VEGF, TIMP1, MMP2, IL-6, and IL-15 in Hela cellsMolecular and Cellular Biochemistry 2014; 389(1-2): 43 doi: 10.1007/s11010-013-1925-y
25
James O. Jones, William M. Moody, Jacqueline D. Shields. Microenvironmental modulation of the developing tumour: an immune‐stromal dialogueMolecular Oncology 2021; 15(10): 2600 doi: 10.1002/1878-0261.12773
26
Jiaying Li, Hongjiao Wu, Hui Gao, Ruihuan Kou, Yuning Xie, Zhi Zhang, Xuemei Zhang. TLR4 promoter rs1927914 variant contributes to the susceptibility of esophageal squamous cell carcinoma in the Chinese populationPeerJ 2021; 9: e10754 doi: 10.7717/peerj.10754
27
Zhifeng He, Xiaofeng Huang, Yanhong Ni, Peihua Shi, Zhiyong Wang, Wei Han, Qingang Hu. Functional toll-like receptor 3 expressed by oral squamous cell carcinoma induced cell apoptosis and decreased migrationOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2014; 118(1): 92 doi: 10.1016/j.oooo.2014.03.012
28
Shaherin Basith, Balachandran Manavalan, Tae Hyeon Yoo, Sang Geon Kim, Sangdun Choi. Roles of toll-like receptors in Cancer: A double-edged sword for defense and offenseArchives of Pharmacal Research 2012; 35(8): 1297 doi: 10.1007/s12272-012-0802-7
29
Shrabon Hasnat, Roosa Hujanen, Bright I. Nwaru, Tuula Salo, Abdelhakim Salem. The Prognostic Value of Toll-Like Receptors in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-AnalysisInternational Journal of Molecular Sciences 2020; 21(19): 7255 doi: 10.3390/ijms21197255
30
Andrés H. Rossi, Ana Farias, Javier E. Fernández, Hernán R. Bonomi, Fernando A. Goldbaum, Paula M. Berguer, Andrzej T Slominski. Brucella spp. Lumazine Synthase Induces a TLR4-Mediated Protective Response against B16 Melanoma in MicePLOS ONE 2015; 10(5): e0126827 doi: 10.1371/journal.pone.0126827
31
Yuan Liu, Xiaodong Guo, Liyuan Wu, Mei Yang, Zhiwei Li, Yinjie Gao, Shuhong Liu, Guangde Zhou, Jingmin Zhao. Lipid rafts promote liver cancer cell proliferation and migration by up-regulation of TLR7 expressionOncotarget 2016; 7(39): 63856 doi: 10.18632/oncotarget.11697
32
Taru Ilmarinen, Jaana Hagström, Caj Haglund, Eeva Auvinen, Ilmo Leivo, Anne Pitkäranta, Leena-Maija Aaltonen. Low Expression of Nuclear Toll-like Receptor 4 in Laryngeal Papillomas Transforming into Squamous Cell CarcinomaOtolaryngology–Head and Neck Surgery 2014; 151(5): 785 doi: 10.1177/0194599814549730
33
Yao Liu, Hao Chen, Zheng Sun, Xiaoxin Chen. Molecular mechanisms of ethanol-associated oro-esophageal squamous cell carcinomaCancer Letters 2015; 361(2): 164 doi: 10.1016/j.canlet.2015.03.006
34
Kai Wu, Yang Yang, Donglei Liu, Yu Qi, Chunyang Zhang, Jia Zhao, Song Zhao. Activation of PPARγ suppresses proliferation and induces apoptosis of esophageal cancer cells by inhibiting TLR4-dependent MAPK pathwayOncotarget 2016; 7(28): 44572 doi: 10.18632/oncotarget.10067
35
Yan Wang, Jinnan Zhang, Wei Zhao, Donglin Wang, Wenduan Ma, Shengtao Shang, Chao Feng, Haixin Yu. MicroRNA expression in esophageal squamous cell carcinoma: Novel diagnostic and prognostic biomarkersMolecular Medicine Reports 2017; 15(6): 3833 doi: 10.3892/mmr.2017.6479
36
Prapti Shrestha, Ross Penninkilampi, Guy D. Eslick. Gastrointestinal Diseases and their Associated Infections2019; : 1 doi: 10.1016/B978-0-323-54843-4.00001-5
37
Sanjay Pandey, Saurabh Singh, Vandana Anang, Anant N. Bhatt, K. Natarajan, Bilikere S. Dwarakanath. Pattern Recognition Receptors in Cancer Progression and MetastasisCancer Growth and Metastasis 2015; 8: CGM.S24314 doi: 10.4137/CGM.S24314
38
Xin Zheng, Song Li, Hui Yang. Roles of Toll-Like Receptor 3 in Human TumorsFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.667454
39
Ximena Maria Muresan, Jan Bouchal, Zoran Culig, Karel Souček. Toll-Like Receptor 3 in Solid Cancer and Therapy ResistanceCancers 2020; 12(11): 3227 doi: 10.3390/cancers12113227
40
JIONG JIANG, LEI DONG, BIN QIN, HAITAO SHI, XIAOYAN GUO, YAN WANG. Decreased expression of TLR7 in gastric cancer tissues and the effects of TLR7 activation on gastric cancer cellsOncology Letters 2016; 12(1): 631 doi: 10.3892/ol.2016.4617
41
K. Nesteruk, M.C.W. Spaander, I. Leeuwenburgh, M.P. Peppelenbosch, G.M. Fuhler. Achalasia and associated esophageal cancer risk: What lessons can we learn from the molecular analysis of Barrett's–associated adenocarcinoma?Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2019; 1872(2): 188291 doi: 10.1016/j.bbcan.2019.04.007
42
D Jia, W Yang, L Li, H Liu, Y Tan, S Ooi, L Chi, L G Filion, D Figeys, L Wang. β-Catenin and NF-κB co-activation triggered by TLR3 stimulation facilitates stem cell-like phenotypes in breast cancerCell Death & Differentiation 2015; 22(2): 298 doi: 10.1038/cdd.2014.145
43
Vasiliki Koliaraki, Ana Henriques, Alejandro Prados, George Kollias. Unfolding innate mechanisms in the cancer microenvironment: The emerging role of the mesenchymeJournal of Experimental Medicine 2020; 217(4) doi: 10.1084/jem.20190457
44
Abdul Arif Khan, Abhinav Shrivastava, Mohsin Khurshid. Normal to cancer microbiome transformation and its implication in cancer diagnosisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2012; 1826(2): 331 doi: 10.1016/j.bbcan.2012.05.005
45
Aadil Sheikh, Joseph Taube, K Leigh Greathouse. Contribution of the microbiota and their secretory products to inflammation and colorectal cancer pathogenesis: the role of toll-like receptorsCarcinogenesis 2021; 42(9): 1133 doi: 10.1093/carcin/bgab060
46
Yazdan Mokhtari, Atieh Pourbagheri‐Sigaroodi, Parisa Zafari, Nader Bagheri, Seyed H. Ghaffari, Davood Bashash. Toll‐like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesisJournal of Cellular and Molecular Medicine 2021; 25(2): 639 doi: 10.1111/jcmm.16214
47
Carlene Petes, Natalya Odoardi, Katrina Gee. The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the EndosomeFrontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.01075
48
Solmaz Ohadian Moghadam, Mohammad Reza Nowroozi. Toll‐like receptors: The role in bladder cancer development, progression and immunotherapyScandinavian Journal of Immunology 2019; 90(6) doi: 10.1111/sji.12818
49
Xiaohong Cen, Shuwen Liu, Kui Cheng. The Role of Toll-Like Receptor in Inflammation and Tumor ImmunityFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00878
50
Zuzanna Urban-Wojciuk, Mohd M. Khan, Benjamin L. Oyler, Robin Fåhraeus, Natalia Marek-Trzonkowska, Aleksandra Nita-Lazar, Ted R. Hupp, David R. Goodlett. The Role of TLRs in Anti-cancer Immunity and Tumor RejectionFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02388
51
Tanja Grimmig, Romana Moench, Jennifer Kreckel, Stephanie Haack, Felix Rueckert, Roberta Rehder, Sudipta Tripathi, Carmen Ribas, Anil Chandraker, Christoph Germer, Martin Gasser, Ana Waaga-Gasser. Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic CancerInternational Journal of Molecular Sciences 2016; 17(12): 2060 doi: 10.3390/ijms17122060
52
Da-Wei Yeh, Li-Rung Huang, Ya-Wen Chen, Chi-Ying F. Huang, Tsung-Hsien Chuang. Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor SignalingJournal of Immunology Research 2016; 2016: 1 doi: 10.1155/2016/4368101
53
S. D. Gowing, J. J. Cool-Lartigue, J. D. Spicer, A. J. E. Seely, L. E. Ferri. Toll-like receptors: exploring their potential connection with post-operative infectious complications and cancer recurrenceClinical & Experimental Metastasis 2020; 37(2): 225 doi: 10.1007/s10585-020-10018-2
54
Jing Liu, Yanbo Wang, Yanjie Chu, Ruiling Xu, Dekai Zhang, Xinhong Wang. Identification of a TLR-Induced Four-lncRNA Signature as a Novel Prognostic Biomarker in Esophageal CarcinomaFrontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00649
55
Yan Hong Ni, Liang Ding, Dong Ya Zhang, Ya Yi Hou, Xiaofeng Huang, Qingang Hu. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinomaHistopathology 2015; 67(5): 730 doi: 10.1111/his.12703
56
Joonas H. Kauppila, Katri S. Selander. Toll-Like Receptors in Esophageal CancerFrontiers in Immunology 2014; 5 doi: 10.3389/fimmu.2014.00200
57
Guangcan Chen, Muming Xu, Jingyao Chen, Liangli Hong, Wenting Lin, Shukun Zhao, Guohong Zhang, Guo Dan, Shuhui Liu. Clinicopathological Features and Increased Expression of Toll-Like Receptor 4 of Gastric Cardia Cancer in a High-Risk Chinese PopulationJournal of Immunology Research 2018; 2018: 1 doi: 10.1155/2018/7132868
58
Lisa A. Ridnour, Robert Y.S. Cheng, Christopher H. Switzer, Julie L. Heinecke, Stefan Ambs, Sharon Glynn, Howard A. Young, Giorgio Trinchieri, David A. Wink. Molecular Pathways: Toll-like Receptors in the Tumor Microenvironment—Poor Prognosis or New Therapeutic OpportunityClinical Cancer Research 2013; 19(6): 1340 doi: 10.1158/1078-0432.CCR-12-0408
59
Tim De Schutter, Graciela Andrei, Dimitri Topalis, Sophie Duraffour, Tania Mitera, Joost van den Oord, Patrick Matthys, Robert Snoeck. Reduced tumorigenicity and pathogenicity of cervical carcinoma SiHa cells selected for resistance to cidofovirMolecular Cancer 2013; 12(1) doi: 10.1186/1476-4598-12-158
60
Olli Helminen, Heikki Huhta, Petri P. Lehenkari, Juha Saarnio, Tuomo J. Karttunen, Joonas H. Kauppila. Nucleic acid-sensing toll-like receptors 3, 7 and 8 in esophageal epithelium, barrett’s esophagus, dysplasia and adenocarcinomaOncoImmunology 2016; 5(5): e1127495 doi: 10.1080/2162402X.2015.1127495
61
Dilraj Kaur, Chakit Arora, Gajendra Pal Singh Raghava. Prognostic Biomarker-Based Identification of Drugs for Managing the Treatment of Endometrial CancerMolecular Diagnosis & Therapy 2021; 25(5): 629 doi: 10.1007/s40291-021-00539-1
62
Nilesh Pandey, Alex Chauhan, Neeraj Jain. TLR4 Polymorphisms and Expression in Solid CancersMolecular Diagnosis & Therapy 2018; 22(6): 683 doi: 10.1007/s40291-018-0361-9
63
Sophia Ran, Nihit Bhattarai, Radhika Patel, Lisa Volk-Draper. Translational Studies on Inflammation2020;  doi: 10.5772/intechopen.85195
64
Emna Fehri, Emna Ennaifer, Monia Ardhaoui, Kaouther Ouerhani, Thalja Laassili, Rahima Bel Haj Rhouma, Ikram Guizani, Samir Boubaker. Expression of Toll-like Receptor 9 Increases with Progression of Cervical Neoplasia in Tunisian Women - A Comparative Analysis of Condyloma, Cervical Intraepithelial Neoplasia and Invasive CarcinomaAsian Pacific Journal of Cancer Prevention 2014; 15(15): 6145 doi: 10.7314/APJCP.2014.15.15.6145
65
Mie Linder Hübbe, Ditte Elisabeth Jæhger, Thomas Lars Andresen, Mads Hald Andersen. Leveraging Endogenous Dendritic Cells to Enhance the Therapeutic Efficacy of Adoptive T-Cell Therapy and Checkpoint BlockadeFrontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.578349
66
Valentino Le Noci, Giancarla Bernardo, Francesca Bianchi, Elda Tagliabue, Michele Sommariva, Lucia Sfondrini. Toll Like Receptors as Sensors of the Tumor Microbial Dysbiosis: Implications in Cancer ProgressionFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.732192
67
Liying Yang, Fritz Francois, Zhiheng Pei. Molecular Pathways: Pathogenesis and Clinical Implications of Microbiome Alteration in Esophagitis and Barrett Esophagus: Figure 1.Clinical Cancer Research 2012; 18(8): 2138 doi: 10.1158/1078-0432.CCR-11-0934